Former Seagen CEO Clay Siegall, Ph.D., will head up a new biotech spun out of Purdue University, less than a year after he stood down from the Seattle-based biopharma in the wake of an arrest for alleged domestic violence.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,